Head-to-head · WeighScore
GoodRx vs LifeRx.md
The verdict
GoodRx takes it — 69.6/100 to 69.3/100, but only just.
GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. LifeRx.md is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | GoodRx | LifeRx.md |
|---|---|---|
| WeighScore | 69.6/100 | 69.3/100 |
| Grade | C | C |
| Scorecard rank | #122 | #133 |
| Semaglutide | Not disclosed | $200/mo |
| Tirzepatide | $299/mo (brand Zepbound) | $275/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #122 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Graded #133 · C
Strengths
- Flat pricing that does not rise with dose: semaglutide ~$200, tirzepatide ~$275 per 5-week supply
- LegitScript certified; prescriptions filled by state-licensed 503A pharmacies
- Available in all 50 states
- HSA and FSA payments accepted
- Required video telehealth consult ensures clinician oversight
Where it loses points
- Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
- Extra fees stack up: ~$30 shipping, $49.95 initial consult, $25 follow-ups
- True monthly cost (~$255) is higher than the headline medication price
- Specific list of supported states not enumerated on site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.